EU POLICY ON ORPHAN DRUGS

被引：1
|
作者：
LEWIS, S
机构：
来源：
LANCET | 1995年 / 345卷 / 8963期
关键词：
D O I：
10.1016/S0140-6736(95)91053-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1500 / 1500
页数：1
相关论文
共 50 条
  • [31] ORPHAN DRUGS
    不详
    SOUTH AFRICAN MEDICAL JOURNAL, 1983, 63 (24): : 914 - 914
  • [32] ORPHAN DRUGS
    Fontanet Sacristan, Juan Manuel
    Torrent-Farnell, Josep
    ARBOR-CIENCIA PENSAMIENTO Y CULTURA, 2018, 194 (789)
  • [33] Orphan drugs
    Novack, Gary D.
    OCULAR SURFACE, 2008, 6 (01): : 52 - 55
  • [34] TIME FOR REIMBURSEMENT FOR ORPHAN DRUGS IN EU5 IN THE LAST THREE YEARS
    Prada, M.
    Benazet, F.
    Berard, I
    Vollmer, L.
    Cuesta, M.
    Guterres, S.
    VALUE IN HEALTH, 2019, 22 : S854 - S854
  • [35] COMPARATIVE ANALYSIS OF LAUNCH PRICES FOR ORPHAN DRUGS IN THE US AND EU4
    Mietus, Z.
    VALUE IN HEALTH, 2024, 27 (06) : S152 - S153
  • [36] Orphan drugs and orphan tests in the USA
    Thoene, JG
    COMMUNITY GENETICS, 2004, 7 (04) : 169 - 172
  • [37] Developing a Patient-Directed Policy Framework for Managing Orphan and Ultra-Orphan Drugs Throughout Their Lifecycle
    Devidas Menon
    Tania Stafinski
    Andrea Dunn
    Durhane Wong-Rieger
    The Patient - Patient-Centered Outcomes Research, 2015, 8 : 103 - 117
  • [38] Developing a Patient-Directed Policy Framework for Managing Orphan and Ultra-Orphan Drugs Throughout Their Lifecycle
    Menon, Devidas
    Stafinski, Tania
    Dunn, Andrea
    Wong-Rieger, Durhane
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2015, 8 (01): : 103 - 117
  • [39] Development of Orphan Drugs in Japan: Characteristics of Orphan Drugs Developed in Japan
    Makoto Shiragami
    Kiyohito Nakai
    Drug information journal : DIJ / Drug Information Association, 2000, 34 (3): : 839 - 846
  • [40] Dose-Finding Studies Among Orphan Drugs Approved in the EU: A Retrospective Analysis
    Schuller, Yvonne
    Gispen-de Wied, Christine
    Hollak, Carla E. M.
    Leufkens, Hubertus G. M.
    Stoyanova-Beninska, Violeta
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (02): : 229 - 244
12345